[6-K] Haleon plc American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc (LSE/NYSE: HLN) filed a Form 6-K reporting progress on the share buyback programme announced 28 March 2025.

Daily trade: on 25 June 2025 the company repurchased 1,006,111 ordinary shares at a volume-weighted average price of 383.38 pence (high 384.80 p, low 380.70 p). All shares will be cancelled.

Completion of first tranche: Haleon has now finished the programme’s first tranche, acquiring 51,036,522 shares for an aggregate consideration of about £200 million. The tranche equates to roughly 0.6 % of the current share base.

Updated share capital: issued share capital is 8,988,533,553 shares of £0.01 each. After deducting 4,080,205 treasury shares, voting shares total 8,984,453,348. Investors should use this figure for FCA disclosure-threshold calculations.

Next steps: management will announce any further tranches separately. The filing contains no earnings, guidance, or operational updates.

Positive

• £200 million of capital returned to shareholders via completed first-tranche buyback.
• Cancellation of 51 million shares delivers slight EPS accretion and signals management’s confidence in intrinsic value.

Negative

• Buyback reduces share count by only ~0.6 %, offering limited near-term financial impact.

Insights

Equity Research Analyst

TL;DR Minor buyback tranche completed; £200 m spent, <0.6 % share reduction—signal of confidence but limited earnings impact.

The first £200 million tranche of Haleon’s March-announced buyback is now complete, bringing cumulative repurchases to 51 million shares—about 0.6 % of the 8.99 billion shares outstanding. While returning cash is shareholder-friendly and marginally accretive to EPS, the scale is modest relative to Haleon’s market capitalisation and free-cash-flow profile. Completion removes an overhang of daily trading but does not materially change leverage or capital allocation flexibility. Future tranches, if sized meaningfully, could influence valuation; however, today’s disclosure is routine, regulatory in nature, and not expected to shift the investment thesis materially.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	26 June 2025 - “Transaction in Own Shares”

99.1

 

Haleon plc: Transaction in own shares and update on the Buyback Programme

26 June 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of the following number of ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under its share buyback programme announced on 28 March 2025 (the "Buyback Programme").

Date of purchase:	25 June 2025
Number of Shares purchased:	1,006,111
Highest price paid per share (p):	384.80
Lowest price paid per share (p):	380.70
Volume weighted average price paid per share (p):	383.38

Following the settlement of the above, the Company's registered share capital is 8,988,533,553 ordinary shares of £0.01 each, of which 4,080,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,984,453,348 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/4578O_1-2025-6-25.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Completion of First Tranche of the Buyback Programme

Following the above transaction, Haleon has completed the First Tranche of the Buyback Programme. In total, the Company repurchased 51,036,522 Shares, all of which were cancelled, for an aggregate consideration of c. £200m.

Any further tranches of the Buyback Programme will be announced in due course.

Enquiries

Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Emma White	+44 7823 523562
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: June 26, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

How many Haleon (HLN) shares were repurchased on 25 June 2025?

1,006,111 ordinary shares were bought at a VWAP of 383.38 p.

What is the total value of Haleon's completed first buyback tranche?

The company spent approximately £200 million to repurchase 51,036,522 shares.

What is Haleon's updated share count with voting rights?

After cancellations, voting shares stand at 8,984,453,348.

Will Haleon launch additional share repurchase tranches?

Management stated that any further tranches will be announced in due course.

Does the 6-K include any earnings or guidance updates?

No. The filing is limited to share buyback activity and capital structure data.